Catherine Rehm

5.0k total citations
42 papers, 2.8k citations indexed

About

Catherine Rehm is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Catherine Rehm has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 25 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Catherine Rehm's work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (22 papers) and Immune Cell Function and Interaction (16 papers). Catherine Rehm is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (22 papers) and Immune Cell Function and Interaction (16 papers). Catherine Rehm collaborates with scholars based in United States, Israel and Australia. Catherine Rehm's co-authors include Frank Maldarelli, Anthony S. Fauci, H. Clifford Lane, Joseph W. Adelsberger, John M. Coffin, John W. Mellors, Hiromi Imamichi, Mary F. Kearney, Robin Dewar and Sarah Palmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Catherine Rehm

42 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Rehm United States 26 2.2k 1.6k 924 524 496 42 2.8k
Hiroyu Hatano United States 28 2.5k 1.1× 1.9k 1.2× 1.2k 1.3× 754 1.4× 750 1.5× 39 3.5k
Mina John Australia 27 1.9k 0.9× 1.4k 0.9× 1.1k 1.2× 756 1.4× 979 2.0× 49 3.3k
Dominique Mathez France 12 1.7k 0.8× 1.4k 0.9× 554 0.6× 646 1.2× 260 0.5× 20 2.2k
JoAnn M. Mican United States 29 2.6k 1.2× 1.9k 1.2× 1.6k 1.7× 807 1.5× 466 0.9× 48 4.1k
Thomas A. Rasmussen Denmark 26 2.2k 1.0× 1.5k 0.9× 916 1.0× 483 0.9× 258 0.5× 63 2.7k
Robert Asaad United States 24 1.3k 0.6× 800 0.5× 1.1k 1.2× 739 1.4× 520 1.0× 40 2.3k
Alain Venet France 32 2.3k 1.1× 1.1k 0.7× 1.8k 1.9× 666 1.3× 291 0.6× 59 3.1k
Wayne B. Dyer Australia 24 1.5k 0.7× 812 0.5× 1.1k 1.2× 493 0.9× 152 0.3× 52 2.3k
Kersten K. Koelsch Australia 20 1.3k 0.6× 1.1k 0.7× 901 1.0× 365 0.7× 264 0.5× 33 2.3k
Steven Schnittman United States 17 1.7k 0.8× 1.3k 0.8× 722 0.8× 609 1.2× 282 0.6× 22 2.2k

Countries citing papers authored by Catherine Rehm

Since Specialization
Citations

This map shows the geographic impact of Catherine Rehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Rehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Rehm more than expected).

Fields of papers citing papers by Catherine Rehm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Rehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Rehm. The network helps show where Catherine Rehm may publish in the future.

Co-authorship network of co-authors of Catherine Rehm

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Rehm. A scholar is included among the top collaborators of Catherine Rehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Rehm. Catherine Rehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jun, Ming Hao, Muhammad Attique Khan, et al.. (2021). A Combination of M50I and V151I Polymorphic Mutations in HIV-1 Subtype B Integrase Results in Defects in Autoprocessing. Viruses. 13(11). 2331–2331. 1 indexed citations
2.
Grossman, Zehava, Wei Shao, Catherine Rehm, et al.. (2018). Early Presence of HIV-1 Subtype C in Washington, D.C.. AIDS Research and Human Retroviruses. 34(8). 680–684. 3 indexed citations
3.
Guzzo, Christina, David M. Ichikawa, Chung Park, et al.. (2017). Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing. Science Immunology. 2(11). 45 indexed citations
4.
Swaminathan, Sanjay, Ju Qiu, Adam Rupert, et al.. (2016). Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation. PLoS ONE. 11(11). e0167091–e0167091. 36 indexed citations
5.
Migueles, Stephen A., Daniel Mendoza, Matthew G. Zimmerman, et al.. (2014). CD8+ T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types. EBioMedicine. 2(1). 46–58. 27 indexed citations
6.
Imamichi, Hiromi, Ven Natarajan, Joseph W. Adelsberger, et al.. (2014). Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS. 28(8). 1091–1099. 47 indexed citations
7.
Kearney, Mary F., Jonathan Spindler, Wei Shao, et al.. (2014). Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy. PLoS Pathogens. 10(3). e1004010–e1004010. 172 indexed citations
8.
Swaminathan, Sanjay, Zonghui Hu, Adam Rupert, et al.. (2014). Plasma Interleukin-27 (IL-27) Levels Are Not Modulated in Patients with Chronic HIV-1 Infection. PLoS ONE. 9(6). e98989–e98989. 15 indexed citations
9.
Hadigan, Colleen, Elizabeth Edwards, Alice Rosenberg, et al.. (2013). Microalbuminuria in HIV Disease. American Journal of Nephrology. 37(5). 443–451. 29 indexed citations
10.
Ganesan, Anuradha, Nancy F. Crum‐Cianflone, Jeanette Higgins, et al.. (2011). High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial. The Journal of Infectious Diseases. 203(6). 756–764. 117 indexed citations
11.
Porter, Brian, Jessica N. Hodge, Margo A. Smith, et al.. (2010). d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clinical Immunology. 136(1). 42–50. 37 indexed citations
12.
Read, Sarah W., Emily J. Ciccone, Rebecca DerSimonian, et al.. (2010). The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants. PLoS ONE. 5(8). e11937–e11937. 39 indexed citations
13.
McMahon, Deborah K., Joyce Jones, Stephen J. Gange, et al.. (2010). Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy. Clinical Infectious Diseases. 50(6). 912–919. 184 indexed citations
14.
Dinoso, Jason B., Ann Wiegand, Sarah Palmer, et al.. (2009). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proceedings of the National Academy of Sciences. 106(23). 9403–9408. 343 indexed citations
15.
Porter, Brian, Joseph A. Kovacs, Richard T. Davey, et al.. (2009). Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels. AIDS. 23(15). 2015–2019. 14 indexed citations
16.
Hahn, Barbara, Catherine Rehm, Joseph W. Adelsberger, et al.. (2008). The Effect of Continuous Versus Pericycle Antiretroviral Therapy on IL-2 Responsiveness. Journal of Interferon & Cytokine Research. 28(7). 455–462. 1 indexed citations
17.
Maldarelli, Frank, Sarah Palmer, Martin King, et al.. (2007). ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia. PLoS Pathogens. 3(4). e46–e46. 267 indexed citations
18.
Kottilil, Shyam, Marie A. O’Shea, Gregg Roby, et al.. (2007). Innate Immunity in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 151–159. 31 indexed citations
19.
Keh, Chris, Barbara Hahn, Claire W. Hallahan, et al.. (2006). Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS. 20(3). 361–369. 11 indexed citations
20.
Kottilil, Shyam, Richard A. Lempicki, Jun Yang, et al.. (2006). Hepatic Histologic Response (HR) to Combination Therapy among HCV/HIV-Coinfected Individuals: Interferon Induces HR Independent of Sustained Virologic Response (SVR). AIDS Research and Human Retroviruses. 22(11). 1091–1098. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyu Hatano Breakdown of academic impact, for papers by Mina John Breakdown of academic impact, for papers by Dominique Mathez Breakdown of academic impact, for papers by JoAnn M. Mican Breakdown of academic impact, for papers by Thomas A. Rasmussen Breakdown of academic impact, for papers by Robert Asaad Breakdown of academic impact, for papers by Alain Venet Breakdown of academic impact, for papers by Wayne B. Dyer Breakdown of academic impact, for papers by Kersten K. Koelsch Breakdown of academic impact, for papers by Steven Schnittman
Rankless by CCL
2026